MEDVi vs Ro
Ro costs $100 less a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Ro
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Visit Ro →If you are choosing between MEDVi and Ro, the first difference is cost: Ro is $100 a month cheaper at the entry price. MEDVi leads our six-part score, 7.1 to 6.7. One of the two has an FDA warning letter on record, covered below.
MEDVi vs Ro price
Ro is the cheaper way in: $149 a month against $249 a month at MEDVi. That is $100 less each month (40% lower), or about $1,200 over a year of treatment.
Medications and formats
MEDVi and Ro do not overlap on medication; only MEDVi lists semaglutide; only Ro lists orforglipron.
On format, MEDVi prices compounded injections, while Ro prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Ro is the only one of the two with a brand-name price.
Where each one treats patients
MEDVi lists 48 states, and Ro does not publish where it ships.
Pricing
MEDVi
Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.
Flat 'Starting at $249' — no intro discount shown.
$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'
$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.
Ro
Additional membership fees apply
What each price covers
Both prices cover the clinician visit and coaching.
MEDVi's price also covers the medication itself and shipping, which Ro does not claim.
Ro's price also covers lab work, which MEDVi does not claim.
MEDVi is silent on lab work.
Ro is silent on shipping.
That matters most for the drug: unless Ro confirms otherwise, budget for medication on top of its listed price.
MEDVi
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Ro
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, MEDVi scores 7.1 and Ro 6.7 out of 10.
MEDVi is stronger on effectiveness (10.0 vs 8.0), accessibility (9.7 vs 5.0) and support (8.5 vs 5.5).
Ro is stronger on value (5.0 vs 2.8) and trust & safety (8.0 vs 6.0).
User experience is within half a point.
MEDVi
7.1/10
Ro
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.
Ro has no FDA warning letter on record with us.
Features & Coverage
| Feature | MEDVi | Ro |
|---|---|---|
| Starting Price | $249/mo | ✓$149/mo |
| Features | 7 features | 7 features |
| States Available | 48 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About MEDVi
Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.
Read our full MEDVi review →About Ro
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Read our full Ro review →Pros & Cons
MEDVi
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves 48 states
- Names 3 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Ro
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits, lab work and coaching
- Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Ro
Watch-outs
- Not included in the monthly price: medication
- Confirm it serves your state before you start the intake
Our Verdict
MEDVi wins this one, 7.1 to 6.7, above all for knowing which pharmacy fills the vial: it names Triad Rx. Ro undercuts it by $100 a month, so if the monthly bill is what decides it, Ro is the pick. Ro fits better if knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC is your priority.
Choose MEDVi if…
You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.
Choose Ro if…
You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →MEDVi vs Ro: FAQ
Close alternatives to MEDVi and Ro
- MEDVi vs Cabana
- MEDVi vs Next Vial
- MEDVi vs Tell Her Doc
- MEDVi vs LIV by WellNow
- Ro vs Amazon One Medical
- Ro vs LillyDirect Foundayo
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.